To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene APTXTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
471 supporting clones for gene APTX back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AY040777   .a 1 to 1907 1 to 1907 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1907/1907
(100 %)
3 diff
(99.9 %id)
AY208829   .a 1 to 1202 1 to 1202 exact AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1202/1202
(100 %)
0 diff
(100 %id)
AK131046 dermoid tumor .a 24 to 1967 1 to 1944   tiling clone, available from FLJ,   1944/1944
(100 %)
1 diff
(100.0 %id)
CR620499 Placenta Cot 25-normalized .a 49 to 1173 1 to 1125       1125/1125
(100 %)
0 diff
(100 %id)
AL549799 placenta, Placenta Cot 25-normalized .a 49 to 583 1 to 535   fully sequenced,   535/535
(100 %)
0 diff
(100 %id)
BG696930 skin .a 241 to 1052 1 to 811       811/814
(99 %)
11 diff
(98.7 %id)
BE254974 eye, retinoblastoma .a 314 to 1008 1 to 692       692/713
(97 %)
9 diff
(98.8 %id)
TI_1241113341   .a 341 to 1424 1148 to 66       1083/1265
(85 %)
10 diff
(99.3 %id)
TI_149295084   .a 348 to 1202 958 to 103   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 856/947
(90 %)
16 diff
(98.4 %id)
TI_1241112387   .a 352 to 1399 1 to 1039       1039/1218
(85 %)
18 diff
(98.6 %id)
TI_154101795   .a 355 to 1202 895 to 56   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 840/951
(88 %)
31 diff
(96.8 %id)
BI259764 cervical carcinoma cell line, cervix .a 364 to 1133 1 to 769       769/810
(94 %)
6 diff
(99.3 %id)
BM711836 eye, human retina .a 369 to 855 1 to 487   fully sequenced, Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 487/487
(100 %)
5 diff
(99.0 %id)
BQ054414 lymph, lymphoma, cell line .a 411 to 1274 1 to 869       869/1022
(85 %)
6 diff
(99.5 %id)
BQ059038 lymph, lymphoma, cell line .a 411 to 1163 1 to 768       768/1126
(68 %)
30 diff
(97.4 %id)
BQ675417 epidermoid carcinoma, cell line, salivary gland .a 442 to 1280 1 to 846       846/879
(96 %)
19 diff
(97.9 %id)
TI_149293322   .a 459 to 1202 812 to 66   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 745/1024
(72 %)
8 diff
(99.3 %id)
BM975069 lung .a 490 to 1202 731 to 17   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 713/715
(99 %)
2 diff
(99.8 %id)
BG289010 bladder, transitional cell papilloma, cell line .a 491 to 1256 1 to 767       767/778
(98 %)
25 diff
(96.8 %id)
BM795411 stomach .a 510 to 1087 1 to 578       578/578
(100 %)
0 diff
(100 %id)
BQ006367 Chondrosarcoma, Left Pelvis .a 527 to 1200 694 to 21   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 674/676
(99 %)
0 diff
(100 %id)
CB131113 Liver .a 531 to 1114 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BU683501 lung .a 531 to 1202 690 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 672/672
(100 %)
1 diff
(99.9 %id)
CA312047 Human Lung Epithelial cells, lung .a 531 to 1202 688 to 17   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 672/672
(100 %)
0 diff
(100 %id)
TI_158433134   .a 536 to 1202 766 to 94   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 673/858
(78 %)
8 diff
(99.1 %id)
AA053755 colon, tumor .a 543 to 861 1 to 318   fully sequenced,   318/318
(100 %)
1 diff
(99.7 %id)
AL573856 placenta, Placenta Cot 25-normalized .a 553 to 1173 621 to 1   fully sequenced,   621/621
(100 %)
5 diff
(99.2 %id)
TI_1948098976   .a 572 to 1033 118 to 579       462/486
(95 %)
6 diff
(98.8 %id)
CV029911 mixed .a 577 to 1082 1 to 506       506/606
(83 %)
1 diff
(99.9 %id)
TI_1948098579   .a 599 to 1082 615 to 128       488/1467
(33 %)
17 diff
(98.9 %id)
TI_1948098850   .a 600 to 1082 611 to 128       484/1332
(36 %)
14 diff
(99.0 %id)
BG740133 skin .a 604 to 1390 1 to 781       781/781
(100 %)
7 diff
(99.2 %id)
BQ446917 Knee, Osteoarthritic Cartilage .a 638 to 1200 581 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 563/566
(99 %)
4 diff
(99.3 %id)
CX784714 human embryonic stem cells .a 641 to 1433 1 to 793       793/793
(100 %)
1 diff
(99.9 %id)
AI924224 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 645 to 1203 558 to 1       558/558
(100 %)
1 diff
(99.9 %id)
CD628476   .a 663 to 1179 1 to 519       519/519
(100 %)
9 diff
(98.3 %id)
BU596713 mixed (pool of 40 RNAs) .a 664 to 1202 1 to 539   AAA   539/545
(98 %)
1 diff
(99.9 %id)
CU454763 epidermis .a 677 to 1522 858 to 13     Submitted on the opposite strand 846/858
(98 %)
0 diff
(100 %id)
AA662697 normal prostate, Prostate .a 701 to 1202 502 to 1       502/502
(100 %)
0 diff
(100 %id)
BP395688 pancreatic islet .a 708 to 1205 1 to 499     Submitted on the opposite strand 499/500
(99 %)
2 diff
(99.6 %id)
N51969 multiple sclerosis lesions .a 719 to 1202 485 to 1       485/485
(100 %)
1 diff
(99.8 %id)
CF528725 placenta .a 723 to 1202 496 to 16   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 481/481
(100 %)
1 diff
(99.8 %id)
AA402356 ovarian tumor, ovary .a 725 to 1100 1 to 376       376/376
(100 %)
0 diff
(100 %id)
CK003377 brain/CNS, Human Brain - Cerebellar Cortex .a 740 to 1366 1 to 626       626/626
(100 %)
3 diff
(99.6 %id)
CN427104 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 747 to 1202 1 to 456   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 456/456
(100 %)
5 diff
(99.0 %id)
T80935 liver and spleen .a 753 to 1079 1 to 339       339/341
(99 %)
16 diff
(95.4 %id)
H79380 liver and spleen .a 754 to 1151 1 to 410       410/423
(96 %)
17 diff
(96.0 %id)
AI004549   .a 780 to 1205 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AI304429 adenocarcinoma, colon .a 780 to 1203 424 to 1       424/424
(100 %)
0 diff
(100 %id)
AA805566 germinal center B cell .a 789 to 1202 469 to 57   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 413/413
(100 %)
1 diff
(99.8 %id)
BM665647 eye, human retina .a 794 to 1202 425 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 409/409
(100 %)
0 diff
(100 %id)
AI001059 breast .a 799 to 1161 379 to 17       363/379
(95 %)
0 diff
(100 %id)
H99710 melanocyte .a 804 to 1202 411 to 1       411/413
(99 %)
12 diff
(97.1 %id)
AA053633 colon, tumor .a 831 to 1200 371 to 1   fully sequenced,   371/371
(100 %)
1 diff
(99.8 %id)
H79269 liver and spleen .a 1602 to 1958 368 to 1   tiling clone,   368/376
(97 %)
15 diff
(96.1 %id)
T80936 liver and spleen .a 1649 to 1963 324 to 3       322/327
(98 %)
0 diff
(100 %id)
BC068107 Lung, large cell carcinoma .b 1 to 1306 1 to 1306 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1306/1306
(100 %)
0 diff
(100 %id)
NM_175073.1   .b 9 to 2076 1 to 2068 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 2068/2068
(100 %)
0 diff
(100 %id)
AY208837 lung small cell carcinoma .b 10 to 1308 1 to 1299 exact AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1299/1299
(100 %)
0 diff
(100 %id)
BE796635 lung, small cell carcinoma .b 41 to 762 1 to 721       721/721
(100 %)
1 diff
(99.9 %id)
BE536018 cervix .b 64 to 694 8 to 633       626/626
(100 %)
13 diff
(98.0 %id)
TI_1241112957   .b 67 to 1199 48 to 1177 K314S L315C L317F R318D P327L ...     1130/1273
(88 %)
13 diff
(99.0 %id)
BC104881 Brain, cerebral cortex, PCR rescued clones .b 68 to 1522 1 to 1455 exact tiling clone,   1455/1455
(100 %)
0 diff
(100 %id)
AY302067   .c 1 to 2102 1 to 2103 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 2103/2103
(100 %)
2 diff
(100.0 %id)
AJ565854 brain .c 138 to 939 1 to 802       802/802
(100 %)
0 diff
(100 %id)
AY208836 lung small cell carcinoma .d 1 to 1335 8 to 1342 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1342/1342
(100 %)
1 diff
(100.0 %id)
BE791102 lung, small cell carcinoma .d 16 to 762 1 to 750       750/750
(100 %)
4 diff
(99.5 %id)
BG214413   .d 1056 to 1337 1 to 278   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 278/278
(100 %)
5 diff
(98.3 %id)
BG197205   .d 1059 to 1335 1 to 277   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 277/278
(99 %)
2 diff
(99.3 %id)
AW947048 lung_tumor .d 1063 to 1299 27 to 267       241/267
(90 %)
7 diff
(97.4 %id)
BG195174   .d 1078 to 1335 20 to 276   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 257/276
(93 %)
9 diff
(96.8 %id)
BX383043   .d 1085 to 2047 974 to 17       958/994
(96 %)
0 diff
(100 %id)
BG538812 lung .d 1108 to 1838 1 to 728       728/837
(86 %)
24 diff
(97.2 %id)
AI139862   .d 1173 to 1338 166 to 1       166/166
(100 %)
0 diff
(100 %id)
FN162462 breast carcinoma .d 1193 to 1274 1 to 82       82/82
(100 %)
0 diff
(100 %id)
EC492657 Prostate .d 1213 to 1301 1 to 89       89/89
(100 %)
0 diff
(100 %id)
CK004024 brain/CNS, Human Brain - Cerebellar Cortex .d 1221 to 1897 1 to 677       677/677
(100 %)
8 diff
(98.9 %id)
AI383618   .d 1225 to 1333 134 to 26   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 109/111
(98 %)
0 diff
(100 %id)
FN076536 breast carcinoma .d 1246 to 1331 1 to 83       83/85
(97 %)
8 diff
(90.6 %id)
BX106637 melanocyte .d 1261 to 1417 1 to 157       157/157
(100 %)
0 diff
(100 %id)
BM718246 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1325 to 1830 1 to 506   tiling clone,   506/506
(100 %)
0 diff
(100 %id)
CA429601 Cell Line, Chondrosarcoma .d 1335 to 2103 778 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 760/761
(99 %)
14 diff
(98.2 %id)
N41516 melanocyte .d 1340 to 1672 1 to 345   fully sequenced,   345/345
(100 %)
8 diff
(97.7 %id)
CD628475   .d 1350 to 1584 243 to 8       236/243
(97 %)
0 diff
(100 %id)
T85870 liver and spleen .d 1355 to 1668 9 to 339       331/341
(97 %)
18 diff
(94.8 %id)
T87367 liver and spleen .d 1355 to 1777 9 to 436       428/437
(97 %)
14 diff
(96.8 %id)
CB529322 Aveolar Macrophage, lung .d 1358 to 2100 761 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 743/744
(99 %)
2 diff
(99.8 %id)
TI_149284213   .d 1359 to 2095 820 to 85   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 736/829
(88 %)
0 diff
(100 %id)
BM717712 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1360 to 1677 1 to 318   fully sequenced, Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 318/318
(100 %)
0 diff
(100 %id)
CB528676 Aveolar Macrophage, lung .d 1364 to 2100 753 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 735/735
(100 %)
3 diff
(99.6 %id)
TI_149281942   .d 1375 to 2097 802 to 78   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 725/725
(100 %)
5 diff
(99.4 %id)
TI_149274452   .d 1388 to 1954 660 to 94   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 567/970
(58 %)
1 diff
(99.9 %id)
BU676131 lung, Primary Lung Epithelial Cells .d 1388 to 1954 585 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 567/575
(98 %)
1 diff
(99.9 %id)
BI850926 pooled .d 1407 to 2097 693 to 1       693/704
(98 %)
2 diff
(99.8 %id)
CA430542 Cell Line, Chondrosarcoma .d 1408 to 2103 714 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 696/696
(100 %)
1 diff
(99.9 %id)
AI885356 anaplastic oligodendroglioma, brain .d 1411 to 1963 553 to 1       553/553
(100 %)
6 diff
(99.0 %id)
TI_149310274   .d 1413 to 2097 765 to 81   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 685/919
(74 %)
3 diff
(99.7 %id)
BU688595 lung, Primary Lung Epithelial Cells .d 1413 to 2097 698 to 14   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 685/688
(99 %)
3 diff
(99.6 %id)
AA629689 lung, lung carcinoma .d 1442 to 1889 448 to 1       448/448
(100 %)
1 diff
(99.8 %id)
BU679780 lung .d 1442 to 2097 669 to 14   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 656/656
(100 %)
0 diff
(100 %id)
AA215869   .d 1455 to 1722 1 to 268       268/268
(100 %)
0 diff
(100 %id)
BU680394 lung, Primary Lung Epithelial Cells .d 1466 to 2095 646 to 21   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 626/628
(99 %)
0 diff
(100 %id)
AI207221 lung .d 1467 to 1687 221 to 1       221/221
(100 %)
3 diff
(98.7 %id)
AI749056 colon .d 1497 to 1955 462 to 3       460/462
(99 %)
0 diff
(100 %id)
AA877210 Kidney .d 1509 to 2101 593 to 1       593/593
(100 %)
1 diff
(99.9 %id)
AV740840 cord Blood .d 1511 to 1950 1 to 430   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 430/430
(100 %)
6 diff
(98.7 %id)
DN919091   .d 1530 to 1835 1 to 306       306/306
(100 %)
1 diff
(99.7 %id)
FN052124 breast carcinoma .d 1546 to 1606 1 to 61       61/62
(98 %)
1 diff
(98.4 %id)
AW196867 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .d 1547 to 2103 557 to 1       557/557
(100 %)
0 diff
(100 %id)
AI744483 colon .d 1565 to 2100 548 to 13   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 536/536
(100 %)
3 diff
(99.5 %id)
AW969287   .d 1579 to 2090 527 to 15     Submitted on the opposite strand 513/527
(97 %)
0 diff
(100 %id)
AW055086 brain, glioblastoma (pooled) .d 1579 to 2092 515 to 1       515/515
(100 %)
1 diff
(99.9 %id)
BF838088 head_neck .d 1590 to 1892 18 to 317       300/324
(92 %)
15 diff
(95.4 %id)
AA534409 colon .d 1594 to 2100 518 to 13   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 506/506
(100 %)
9 diff
(98.3 %id)
AI806987 pooled .d 1600 to 2094 495 to 1       495/495
(100 %)
6 diff
(98.8 %id)
AW337800 lymph node, lymphoma, follicular mixed small and largecell .d 1601 to 1950 350 to 1       350/350
(100 %)
2 diff
(99.5 %id)
AI824154 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 1604 to 2098 495 to 1       495/495
(100 %)
0 diff
(100 %id)
AI378655 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1612 to 2104 495 to 3       493/495
(99 %)
0 diff
(100 %id)
CN427109 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1620 to 1963 1 to 344   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 344/344
(100 %)
0 diff
(100 %id)
AI032627 parathyroid gland, parathyroid tumor .d 1626 to 1955 338 to 9       330/338
(97 %)
0 diff
(100 %id)
AI619573 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1626 to 1955 336 to 7       330/336
(98 %)
0 diff
(100 %id)
AI572649 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 1627 to 2098 477 to 6       472/477
(98 %)
0 diff
(100 %id)
N33536 melanocyte .d 1642 to 2101 461 to 1   fully sequenced,   461/461
(100 %)
1 diff
(99.8 %id)
AW167221 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 1644 to 2098 460 to 6       455/460
(98 %)
0 diff
(100 %id)
BM674915 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1647 to 2097 464 to 14   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 451/451
(100 %)
0 diff
(100 %id)
AI081440 senescent fibroblast .d 1655 to 2097 458 to 16   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 443/443
(100 %)
2 diff
(99.6 %id)
AI280118 pooled .d 1661 to 2098 439 to 3       437/439
(99 %)
0 diff
(100 %id)
CA434836 lung, Metastatic Chondrosarcoma .d 1662 to 2095 454 to 21   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 434/436
(99 %)
0 diff
(100 %id)
N49274 multiple sclerosis lesions .d 1665 to 2094 432 to 1       432/432
(100 %)
2 diff
(99.6 %id)
BF244131 brain, glioblastoma .d 1666 to 2099 1 to 431       431/461
(93 %)
4 diff
(99.2 %id)
AA923481 Kidney .d 1668 to 2095 428 to 1       428/428
(100 %)
0 diff
(100 %id)
DB547058 hippocampus .d 1670 to 2097 1 to 427     Submitted on the opposite strand 427/427
(100 %)
2 diff
(99.6 %id)
AI081442 senescent fibroblast .d 1670 to 2098 436 to 8       429/436
(98 %)
0 diff
(100 %id)
AA436601   .d 1671 to 2098 437 to 10       428/437
(97 %)
0 diff
(100 %id)
BM144315 leukopheresis .d 1671 to 2098 444 to 16       429/444
(96 %)
5 diff
(98.9 %id)
BM144262 leukopheresis .d 1675 to 2092 439 to 22   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 418/418
(100 %)
0 diff
(100 %id)
FN167763 breast carcinoma .d 1679 to 1792 1 to 117       117/117
(100 %)
6 diff
(94.9 %id)
AA878229 carcinoid, lung .d 1679 to 1929 1 to 251     Submitted on the opposite strand 251/251
(100 %)
0 diff
(100 %id)
N35589 melanocyte .d 1681 to 2097 420 to 1       420/421
(99 %)
3 diff
(99.3 %id)
BM712788 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1685 to 2082 17 to 414   fully sequenced, Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 398/414
(96 %)
7 diff
(98.4 %id)
AI372952 uterus .d 1686 to 2104 423 to 5       419/423
(99 %)
0 diff
(100 %id)
AW243515 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .d 1696 to 2095 413 to 14       400/413
(96 %)
0 diff
(100 %id)
AW243805 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 1698 to 2097 420 to 21   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 400/400
(100 %)
2 diff
(99.5 %id)
AA845572 parathyroid gland, parathyroid tumor .d 1700 to 2098 404 to 6       399/404
(98 %)
0 diff
(100 %id)
AI083586 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1702 to 2100 399 to 1       399/399
(100 %)
0 diff
(100 %id)
AW591957 pooled .d 1705 to 2092 408 to 21   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 388/391
(99 %)
0 diff
(100 %id)
AI280373 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1710 to 2101 393 to 2       392/393
(99 %)
0 diff
(100 %id)
AA350896 brain .d 1711 to 2092 382 to 1       382/382
(100 %)
0 diff
(100 %id)
BM676129 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1722 to 2097 389 to 14   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 376/376
(100 %)
1 diff
(99.8 %id)
AA470656 colon .d 1749 to 2097 349 to 1       349/349
(100 %)
1 diff
(99.8 %id)
AW044129 pooled .d 1755 to 2098 348 to 5       344/348
(98 %)
0 diff
(100 %id)
AI698881 colon .d 1759 to 2094 336 to 1       336/336
(100 %)
0 diff
(100 %id)
H24762 breast .d 1778 to 2100 328 to 1       328/329
(99 %)
8 diff
(97.6 %id)
DN920459   .d 1784 to 2095 317 to 6       312/317
(98 %)
0 diff
(100 %id)
H22989.
matches multiple genes
whole brain .d 1792 to 2097 331 to 21   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base), also hits gene GRIA1 311/324
(95 %)
8 diff
(97.6 %id)
AA494365 colon .d 1794 to 2107 328 to 15   tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 314/314
(100 %)
0 diff
(100 %id)
AL039430 testis .d 1824 to 2097 1 to 274   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 274/274
(100 %)
0 diff
(100 %id)
AI094708 brain, glioblastoma (pooled) .d 1919 to 2098 180 to 1       180/180
(100 %)
0 diff
(100 %id)
AI278267 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1919 to 2101 184 to 2       183/184
(99 %)
0 diff
(100 %id)
DA603792   .e -8 to 501 2 to 511   tiling clone, capped   510/510
(100 %)
0 diff
(100 %id)
AY208834   .e 7 to 1127 1 to 1124 K175M V176Q Y177V K178Y D179K ... tiling clone,   1124/1124
(100 %)
2 diff
(99.9 %id)
AV714486   .e 7 to 708 1 to 703   tiling clone,   699/703
(99 %)
11 diff
(98.5 %id)
DB319995   .e 1383 to 1906 524 to 1   tiling clone,   524/524
(100 %)
0 diff
(100 %id)
AL700775 human skeletal muscle .f -10 to 663 1 to 674       674/674
(100 %)
1 diff
(99.9 %id)
AL699924 human skeletal muscle .f -10 to 663 1 to 674       674/674
(100 %)
1 diff
(99.9 %id)
AK055672   .f -9 to 2002 1 to 2012 exact tiling clone, available from FLJ,   2012/2012
(100 %)
0 diff
(100 %id)
CX787509 human embryonic stem cells .f -9 to 818 1 to 828       828/828
(100 %)
5 diff
(99.4 %id)
NM_175069.1   .f -9 to 2008 1 to 2018 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 2018/2018
(100 %)
0 diff
(100 %id)
DA344142 substantia nigra .f -8 to 530 17 to 555   capped   539/540
(99 %)
1 diff
(99.9 %id)
DA521076 brain .f -8 to 540 2 to 551   capped   550/555
(99 %)
2 diff
(99.7 %id)
DA837519 placenta .f -8 to 564 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DB002305 breast, tumor tissue .f -8 to 533 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
DB003036 breast, tumor tissue .f -8 to 539 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DB016534 esophageal, tumor tissue .f -8 to 564 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB028899 testis .f -8 to 536 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
BJ990381 hepatoblastoma .f 1 to 598 3 to 600       598/600
(99 %)
5 diff
(99.2 %id)
CD690695 normal nasopharynx .f 2 to 461 36 to 495       460/495
(92 %)
7 diff
(98.6 %id)
DW420625 Liver .f 2 to 293 9 to 300       292/300
(97 %)
8 diff
(97.4 %id)
DR001523 fetal brain .f 3 to 675 7 to 679       673/679
(99 %)
6 diff
(99.2 %id)
DA258213 caudate nucleus .f 8 to 582 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA908488   .f 9 to 557 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
T34269 blood, white blood cells .f 10 to 347 1 to 339       339/339
(100 %)
2 diff
(99.5 %id)
DB251584 uterus .f 10 to 540 2 to 532   capped   531/534
(99 %)
3 diff
(99.5 %id)
BI548943 brain, hippocampus .f 11 to 780 1 to 776       776/776
(100 %)
12 diff
(98.5 %id)
DA051118   .f 12 to 611 2 to 600   capped   599/599
(100 %)
1 diff
(99.9 %id)
DA207328 brain .f 12 to 581 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BM194072 leukopheresis .f 12 to 515 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
DB109049 thymus .f 12 to 579 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA062905 cerebellum .f 14 to 571 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BE798258 lung, small cell carcinoma .f 14 to 794 10 to 789       780/928
(84 %)
19 diff
(98.0 %id)
TI_44166731   .f 17 to 780 135 to 904       770/904
(85 %)
14 diff
(98.5 %id)
AU253559 neuroblastoma .f 23 to 678 1 to 652     Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 652/652
(100 %)
7 diff
(99.0 %id)
BI256015 cervical carcinoma cell line, cervix .f 24 to 776 1 to 755       755/756
(99 %)
11 diff
(98.6 %id)
T08510   .f 25 to 425 1 to 402       402/407
(98 %)
3 diff
(99.3 %id)
R17982 whole brain .f 25 to 401 1 to 384       384/430
(89 %)
17 diff
(96.1 %id)
BI255946 cervical carcinoma cell line, cervix .f 25 to 753 1 to 742       742/745
(99 %)
25 diff
(96.7 %id)
CX165684 human embryonic stem cells differentiated toan early endodermal cell type .f 25 to 788 1 to 764       764/764
(100 %)
0 diff
(100 %id)
DA695287   .f 25 to 596 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
BP873161 embryonal kidney .f 26 to 356 1 to 331       331/331
(100 %)
0 diff
(100 %id)
DN997423 breast cancer, Mammary gland (cancer tissue) .f 26 to 742 9 to 725       717/725
(98 %)
6 diff
(99.2 %id)
DB453027.
matches multiple genes
testis .f 27 to 520 1 to 494     also hits gene fawroybu 494/494
(100 %)
2 diff
(99.6 %id)
DA703248   .f 27 to 559 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
DA848087 placenta .f 27 to 596 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DB060403 testis .f 27 to 564 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA141515 alzheimer cortex .f 28 to 578 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA845980 placenta .f 28 to 595 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA939823 Spleen .f 28 to 625 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DB017135 esophageal, tumor tissue .f 28 to 588 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
DB041259 testis .f 28 to 580 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB048261 testis .f 28 to 581 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA702952   .f 29 to 578 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA551254   .f 30 to 556 2 to 528   capped   527/527
(100 %)
1 diff
(99.9 %id)
DA054353 cerebellum .f 33 to 588 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA465698   .f 33 to 590 2 to 559   capped   558/568
(98 %)
1 diff
(99.9 %id)
BU526717 epidermoid carcinoma, cell line, lung .f 49 to 930 1 to 884       884/912
(96 %)
9 diff
(99.1 %id)
AL544906 placenta, Placenta Cot 25-normalized .f 51 to 802 1 to 748       748/748
(100 %)
28 diff
(96.3 %id)
BI762877 pooled colon, kidney, stomach .f 51 to 776 12 to 737       729/741
(98 %)
8 diff
(99.0 %id)
TI_57150334   .f 51 to 776 75 to 800       726/804
(90 %)
8 diff
(99.1 %id)
CV575576 cornea, eye .f 51 to 669 11 to 629       621/629
(98 %)
6 diff
(99.1 %id)
DA363414 subthalamic nucleus .f 53 to 526 76 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DR156932 human embryonic stem cells differentiated toan early endodermal cell type .f 53 to 757 71 to 775       775/775
(100 %)
0 diff
(100 %id)
DA680261   .f 53 to 307 76 to 330   capped   329/329
(100 %)
1 diff
(99.7 %id)
DR004856 placenta .f 53 to 745 16 to 708       693/708
(97 %)
7 diff
(99.1 %id)
TI_57214818   .f 72 to 930 36 to 897       862/897
(96 %)
15 diff
(98.4 %id)
BI752679 brain .f 73 to 930 1 to 861       861/861
(100 %)
9 diff
(99.0 %id)
CN427107 embryonic stem cells, DMSO-treated H9 cellline .f 244 to 810 1 to 567       567/567
(100 %)
5 diff
(99.2 %id)
AY208842 lymphoma .f 369 to 1240 1 to 872   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 872/872
(100 %)
0 diff
(100 %id)
BG025099 lymph, lymphoma, cell line .f 369 to 1140 1 to 773       773/774
(99 %)
17 diff
(97.9 %id)
AL570852 placenta, Placenta Cot 25-normalized .f 1001 to 1828 840 to 1       840/929
(90 %)
46 diff
(95.1 %id)
AU253560 neuroblastoma .f 1344 to 2002 700 to 42   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 659/659
(100 %)
2 diff
(99.7 %id)
BJ990382 hepatoblastoma .f 1443 to 1982 540 to 1       540/540
(100 %)
0 diff
(100 %id)
DB023942 testis .g 1 to 540 3 to 542   tiling clone, capped   541/541
(100 %)
1 diff
(99.9 %id)
CD698805 normal nasopharynx .g 2 to 513 11 to 522       512/522
(98 %)
7 diff
(98.7 %id)
AY208832 Kidney .g 3 to 1025 1 to 1023 exact     1023/1023
(100 %)
0 diff
(100 %id)
DB035858 testis .g 8 to 582 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DA482693   .g 24 to 596 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
AA280115 germinal center B cell .g 24 to 284 1 to 260       260/260
(100 %)
1 diff
(99.7 %id)
DB059069 testis .g 26 to 555 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
CB142359 Liver .g 32 to 417 1 to 386       386/386
(100 %)
0 diff
(100 %id)
CD243118 brain, Pituitary .g 41 to 831 1 to 793       793/871
(91 %)
10 diff
(98.9 %id)
DA906936   .g 43 to 602 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BI832053 brain, medulla .g 51 to 857 13 to 819       807/823
(98 %)
8 diff
(99.1 %id)
TI_57173250   .g 51 to 857 13 to 819       807/823
(98 %)
8 diff
(99.1 %id)
AY208830 testis .g 53 to 1042 76 to 1065 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1065/1065
(100 %)
0 diff
(100 %id)
BG718118 testis .g 53 to 859 81 to 880       880/912
(96 %)
31 diff
(96.7 %id)
AA281760 germinal center B cell .g 581 to 1042 462 to 1       462/462
(100 %)
0 diff
(100 %id)
BQ957536 carcinoma, cell line, Prostate .h 1 to 931 8 to 939       939/939
(100 %)
26 diff
(97.3 %id)
BX538161 human endometrium .h 1 to 1972 3 to 1974 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1974/1974
(100 %)
0 diff
(100 %id)
DA846146 placenta .h 1 to 556 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
CF596376 Stomach, adenocarcinoma .h 7 to 468 1 to 470       470/1039
(45 %)
19 diff
(98.2 %id)
BQ939344 carcinoma, cell line, Prostate .h 8 to 706 1 to 702       702/988
(71 %)
12 diff
(98.8 %id)
DA987000 synovial membrane tissue from rheumatioidarthritis .h 10 to 473 2 to 465   capped   464/464
(100 %)
0 diff
(100 %id)
BM923624 pooled colon, kidney, stomach .h 23 to 700 78 to 764       685/1344
(50 %)
15 diff
(98.9 %id)
CB127456 cervix, Uterine .h 27 to 455 1 to 429       429/429
(100 %)
3 diff
(99.4 %id)
DB163014 thymus .h 33 to 618 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DA047562   .h 53 to 549 70 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB027446 testis .i 1 to 589 2 to 590   tiling clone, capped   589/589
(100 %)
1 diff
(99.9 %id)
BM147155 leukopheresis .i 4 to 473 1 to 470       470/471
(99 %)
4 diff
(99.2 %id)
DA888033   .i 6 to 567 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DB272168 uterus .i 7 to 556 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BX361817   .i 9 to 960 25 to 970   tiling clone,   946/970
(97 %)
11 diff
(98.9 %id)
DB478408 hippocampus .i 21 to 484 1 to 464       464/464
(100 %)
0 diff
(100 %id)
BQ720673 sympathetic trunk .i 41 to 945 1 to 915   tiling clone,   915/915
(100 %)
21 diff
(97.8 %id)
DB042208 testis .j 1 to 567 2 to 568   tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
BG428286 Kidney .j 34 to 667 1 to 646       646/1036
(62 %)
22 diff
(97.9 %id)
AY208833 Kidney .j 47 to 1158 1 to 1112 exact tiling clone,   1112/1112
(100 %)
0 diff
(100 %id)
AY208831 skin .k 1 to 1734 1 to 1734 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1734/1734
(100 %)
0 diff
(100 %id)
BG674030 skin .k 1 to 807 1 to 826       800/903
(88 %)
23 diff
(97.5 %id)
DA813665   .l 1 to 562 2 to 562   tiling clone, capped   561/561
(100 %)
2 diff
(99.7 %id)
DA663462   .l 319 to 873 2 to 556   tiling clone, capped   555/555
(100 %)
0 diff
(100 %id)
DA543540   .m 1 to 557 2 to 559   tiling clone, capped   558/558
(100 %)
1 diff
(99.9 %id)
BX423737 fetal liver, Liver .m 11 to 913 1 to 901       901/901
(100 %)
7 diff
(99.3 %id)
BM742702 stomach .m 13 to 620 1 to 608       608/608
(100 %)
1 diff
(99.9 %id)
DB031406 testis .m 15 to 625 2 to 612   capped   611/611
(100 %)
0 diff
(100 %id)
DA547514   .m 18 to 577 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA421383 cervix .m 20 to 590 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BF034624 adenocarcinoma, ovary .m 32 to 689 5 to 663       660/1071
(61 %)
18 diff
(98.4 %id)
BC032650 Lymph, lymphoma .m 36 to 1907 12 to 1883 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1872/1872
(100 %)
0 diff
(100 %id)
BM464980 lymph, lymphoma, cell line .m 37 to 858 1 to 836       836/1135
(73 %)
21 diff
(98.2 %id)
NM_175072.1   .m 38 to 2060 1 to 2023 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 2023/2023
(100 %)
0 diff
(100 %id)
BQ671206 epidermoid carcinoma, cell line, salivary gland .m 247 to 1168 1 to 924       924/933
(99 %)
30 diff
(96.8 %id)
BQ674027 epidermoid carcinoma, cell line, salivary gland .m 247 to 1191 1 to 952 K186*     952/955
(99 %)
15 diff
(98.5 %id)
BQ669615 epidermoid carcinoma, cell line, salivary gland .m 247 to 1117 1 to 877       877/910
(96 %)
23 diff
(97.5 %id)
AL551324 placenta, Placenta Cot 25-normalized .n 1 to 966 1 to 963       963/963
(100 %)
7 diff
(99.3 %id)
AL551395 placenta, Placenta Cot 25-normalized .n 1 to 965 1 to 963   tiling clone,   963/963
(100 %)
4 diff
(99.6 %id)
CN427106 embryonic stem cells, cell lines H1, H7, andH9 .n 2 to 498 1 to 497       497/497
(100 %)
1 diff
(99.8 %id)
AY208839 melanotic melanoma .n 4 to 2096 1 to 2093 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 2093/2093
(100 %)
3 diff
(99.9 %id)
BE895537 melanotic melanoma, skin .n 4 to 675 1 to 683       683/893
(76 %)
32 diff
(96.5 %id)
N53816.
matches multiple genes
multiple sclerosis lesions .n 39 to 234 1 to 197     also hits gene KAT2A 197/197
(100 %)
2 diff
(99.0 %id)
AL575061 placenta, Placenta Cot 25-normalized .n 1003 to 2049 1072 to 27   tiling clone,   1046/1081
(96 %)
3 diff
(99.8 %id)
AL574972 placenta, Placenta Cot 25-normalized .n 1069 to 2075 1006 to 1       1006/1006
(100 %)
7 diff
(99.4 %id)
AY208835 hypothalamus .o 1 to 1165 1 to 1165 exact tiling clone,   1165/1165
(100 %)
5 diff
(99.6 %id)
BG708528 brain, hypothalamus .o 1 to 731 1 to 733       733/848
(86 %)
9 diff
(99.0 %id)
AY302068   .p 1 to 2097 1 to 2098 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 2098/2098
(100 %)
2 diff
(100.0 %id)
AJ565853 brain .p 138 to 934 1 to 797       797/797
(100 %)
0 diff
(100 %id)
AY208840 muscle .q 1 to 1199 1 to 1199 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1199/1199
(100 %)
0 diff
(100 %id)
BX487106   .q 6 to 575 1 to 570       570/570
(100 %)
3 diff
(99.5 %id)
DA682206 ovary .q 12 to 571 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA831392 placenta .q 12 to 745 2 to 736   capped Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 735/756
(97 %)
8 diff
(99.0 %id)
DB051088 testis .q 14 to 585 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA937003 Spleen .q 25 to 585 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BG772447 testis .q 27 to 596 1 to 571       571/583
(97 %)
11 diff
(98.2 %id)
BM919347 pooled pancreas and spleen .q 27 to 888 1 to 869       869/1029
(84 %)
14 diff
(98.7 %id)
DA609599   .q 27 to 586 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA002682   .q 28 to 587 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA018501   .q 28 to 589 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB021584 testis .q 28 to 581 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DA282799 corpus callosum .q 33 to 558 2 to 528   capped   527/527
(100 %)
1 diff
(99.9 %id)
AA350897 brain .q 45 to 448 1 to 405       405/405
(100 %)
1 diff
(99.8 %id)
BI334527 cervical carcinoma cell line, cervix .q 51 to 721 21 to 703       684/1171
(58 %)
30 diff
(97.5 %id)
CX757783 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .q 167 to 821 1 to 649       649/850
(76 %)
14 diff
(98.4 %id)
DB377043 placenta .q 1419 to 1961 548 to 1   tiling clone, Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 548/572
(95 %)
18 diff
(96.9 %id)
DA750554   .r -8 to 577 2 to 587   tiling clone, capped   586/587
(99 %)
2 diff
(99.7 %id)
CF146588 CNCAP(3)T-225 cell line, Prostate .r 18 to 650 1 to 633       633/633
(100 %)
5 diff
(99.3 %id)
CF122027 CNCAP(3)T-225 cell line, Prostate .r 18 to 695 1 to 679       677/679
(99 %)
8 diff
(98.9 %id)
TI_154179064   .r 24 to 883 75 to 919   tiling clone,   845/972
(86 %)
21 diff
(97.9 %id)
TI_154181444   .r 24 to 981 69 to 1009   tiling clone,   941/941
(100 %)
33 diff
(96.5 %id)
DA575412   .r 53 to 543 76 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
CR602856 T cells (Jurkat cell line) Cot10-normalized .s 1 to 1310 4 to 1313 exact tiling clone,   1313/1313
(100 %)
0 diff
(100 %id)
AL559375 T cells from T cell leukemia .s 1 to 704 4 to 698   fully sequenced,   698/698
(100 %)
4 diff
(99.5 %id)
CN427110 embryonic stem cells, DMSO-treated H9 cellline .s 18 to 507 1 to 488       488/488
(100 %)
9 diff
(98.2 %id)
AY208841 retinoblastoma .s 307 to 2104 5 to 1802 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1802/1802
(100 %)
2 diff
(99.9 %id)
BQ958540 carcinoma, cell line, Prostate .s 310 to 904 1 to 598       598/1091
(54 %)
7 diff
(99.4 %id)
BE781210 eye, retinoblastoma .s 323 to 960 1 to 639       639/652
(98 %)
3 diff
(99.6 %id)
N46755 multiple sclerosis lesions .s 423 to 796 1 to 383       383/385
(99 %)
11 diff
(97.2 %id)
H12115 whole brain .s 458 to 790 1 to 334       334/334
(100 %)
4 diff
(98.9 %id)
BX426847 fetal liver, Liver .s 547 to 1044 361 to 848       488/542
(90 %)
17 diff
(96.9 %id)
AU155753.
matches multiple genes
placenta .s 547 to 1009 459 to 1     also hits gene F13A1 459/460
(99 %)
10 diff
(97.9 %id)
AL581010 T cells from T cell leukemia .s 643 to 1310 668 to 1   fully sequenced,   668/668
(100 %)
7 diff
(99.0 %id)
BE938600 testis_normal .s 797 to 1034 1 to 237       237/237
(100 %)
9 diff
(96.3 %id)
AW362125 colon .s 960 to 1052 90 to 1       90/104
(86 %)
3 diff
(97.2 %id)
AK000164 colon .t 1 to 1987 1 to 1988 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1988/1988
(100 %)
2 diff
(99.9 %id)
AY302069   .t 1 to 1987 1 to 1988 exact AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1988/1988
(100 %)
2 diff
(99.9 %id)
NM_017692.2   .t 1 to 1998 1 to 1998 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1998/1998
(100 %)
0 diff
(100 %id)
AY302070   .u 1 to 1982 1 to 1983 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1983/1983
(100 %)
2 diff
(99.9 %id)
AJ575566 brain .u 138 to 819 1 to 682       682/682
(100 %)
0 diff
(100 %id)
DB054527 testis .va 1 to 567 2 to 569   tiling clone, capped   568/568
(100 %)
1 diff
(99.9 %id)
BU176995 melanotic melanoma, skin .va 114 to 980 1 to 872 S177R F180X C184W K186X N192E ... tiling clone,   872/872
(100 %)
10 diff
(98.9 %id)
AJ565855 brain .vb 1 to 640 1 to 640 exact tiling clone,   640/640
(100 %)
0 diff
(100 %id)
AY302071   .vc 1 to 1875 1 to 1876 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1876/1876
(100 %)
2 diff
(99.9 %id)
DA539687 Kidney .vd 1 to 598 2 to 599 exact tiling clone, capped   598/598
(100 %)
0 diff
(100 %id)
AA305448 colon .vd 97 to 445 10 to 359       350/359
(97 %)
7 diff
(98.1 %id)
TI_57200033   .ve 1 to 962 57 to 1029 S154F I155H P156S Q157S L158A ... tiling clone,   973/1030
(94 %)
34 diff
(96.7 %id)
BI818746 pooled brain, lung, testis .ve 11 to 962 1 to 963 S154F I155H P156S Q157S L158A ... tiling clone,   963/964
(99 %)
28 diff
(97.1 %id)
AW947990 marrow .vf 1 to 292 293 to 2     Submitted on the opposite strand 292/294
(99 %)
0 diff
(100 %id)
AW947991 marrow .vf 1 to 292 288 to 3   tiling clone, Submitted on the opposite strand 286/289
(98 %)
0 diff
(100 %id)
DA664623   .vf 42 to 594 2 to 554 exact tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
DB263240 uterus .vg 1 to 593 2 to 594 exact tiling clone, capped   593/593
(100 %)
0 diff
(100 %id)
AW013823   .vh 1 to 397 398 to 1   tiling clone,   398/398
(100 %)
2 diff
(99.5 %id)
AI203777 lung .vh 232 to 364 133 to 1       133/133
(100 %)
0 diff
(100 %id)
H52158 pineal gland .vh 390 to 859 1 to 473   AAA Submitted on the opposite strand 473/473
(100 %)
7 diff
(98.6 %id)
AI375595 brain, glioblastoma (pooled) .vh 391 to 846 1 to 456     Submitted on the opposite strand 456/456
(100 %)
0 diff
(100 %id)
AI375965   .vh 391 to 864 1 to 474   tiling clone, Submitted on the opposite strand 474/478
(99 %)
1 diff
(99.8 %id)
AI421806 brain, glioblastoma (pooled) .vh 391 to 859 1 to 469   AAA Submitted on the opposite strand 469/469
(100 %)
9 diff
(98.1 %id)
AW008706 brain, glioblastoma (pooled) .vh 391 to 759 1 to 370     Submitted on the opposite strand 370/370
(100 %)
2 diff
(99.5 %id)
BE674682 B-cell, chronic lymphotic leukemia .vh 391 to 844 1 to 454     Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
BE858722 brain, glioblastoma (pooled) .vh 391 to 845 1 to 455     Submitted on the opposite strand 455/455
(100 %)
2 diff
(99.6 %id)
BX106626 brain, pineal gland .vh 393 to 859 481 to 15   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 467/467
(100 %)
3 diff
(99.4 %id)
BE855865 brain, glioblastoma (pooled) .vh 393 to 546 1 to 154     Submitted on the opposite strand 154/154
(100 %)
4 diff
(97.5 %id)
BE045388 carcinoid, lung .vh 400 to 835 1 to 436     Submitted on the opposite strand 436/436
(100 %)
4 diff
(99.1 %id)
AI423239 brain, glioblastoma (pooled) .vh 409 to 846 1 to 438     Submitted on the opposite strand 438/438
(100 %)
0 diff
(100 %id)
AI760843 B-cell, chronic lymphotic leukemia .vh 409 to 859 1 to 450   AAA Submitted on the opposite strand 450/450
(100 %)
3 diff
(99.4 %id)
AI016494   .vh 414 to 850 1 to 438     Submitted on the opposite strand 438/438
(100 %)
7 diff
(98.5 %id)
AI761783 colon, colon tumor, RER+ .vh 439 to 846 1 to 408     Submitted on the opposite strand 408/408
(100 %)
4 diff
(99.1 %id)
DN997128 breast cancer, Mammary gland (cancer tissue) .vi 1 to 485 5 to 489 G74X tiling clone,   489/489
(100 %)
4 diff
(99.2 %id)
CA942433 Pancreas, Purified pancreatic islet .vj 1 to 644 7 to 643 E15G P36T P37L P38L P39R ... tiling clone,   638/643
(99 %)
7 diff
(99.0 %id)
CK903042 Pancreas, Purified pancreatic islet .vj 47 to 615 1 to 562 E15G P36T P37L P38L P39R ...   Submitted on the opposite strand 562/562
(100 %)
7 diff
(98.8 %id)
CA867139 Pancreas, Purified pancreatic islet .vj 285 to 797 523 to 11   tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 513/513
(100 %)
0 diff
(100 %id)
BX507197 Liver .vk 1 to 708 1 to 708   tiling clone,   708/708
(100 %)
15 diff
(97.9 %id)
BF330585 breast .vk 644 to 745 102 to 1   tiling clone,   102/102
(100 %)
1 diff
(99.1 %id)
BF956357 nervous_normal .vk 861 to 1318 1 to 457   tiling clone,   457/457
(100 %)
4 diff
(99.2 %id)
BF963026 nervous_normal .vk 869 to 1318 10 to 459   tiling clone,   450/459
(98 %)
6 diff
(98.7 %id)
FN048644 breast carcinoma .vk 980 to 1032 1 to 53       53/54
(98 %)
1 diff
(98.2 %id)
CN413200 embryonic stem cells, cell lines H1, H7, andH9 .vk 1225 to 1833 1 to 603   tiling clone,   603/603
(100 %)
2 diff
(99.7 %id)
CV326975 uterus_tumor .vk 1364 to 1667 22 to 320       299/342
(87 %)
7 diff
(98.0 %id)
BG743014 skin .vk 1773 to 2391 108 to 735   tiling clone,   729/738
(98 %)
12 diff
(98.4 %id)
BY795853 eye .vk 2215 to 2847 1 to 633 exact tiling clone,   633/633
(100 %)
0 diff
(100 %id)
DA040188 bladder .vk 2310 to 2829 2 to 523   capped   520/522
(99 %)
3 diff
(99.5 %id)
DA710877   .vl 1 to 552 2 to 553 exact tiling clone, capped   552/552
(100 %)
0 diff
(100 %id)
DB115347 thymus .vm -8 to 537 2 to 548 R43X G44W E46R T47D K48Q ... tiling clone, capped   547/547
(100 %)
1 diff
(99.9 %id)
DB230298 trachea .vn -8 to 588 2 to 601 V4C N5E L6F S7V V8R ... tiling clone, capped   600/600
(100 %)
3 diff
(99.5 %id)
DB284074 uterus .vn 15 to 559 2 to 547 W61X S62V tiling clone, capped   546/546
(100 %)
1 diff
(99.9 %id)
BX352861 Neuroblastoma Cot 10-normalized .vo 130 to 891 140 to 892   tiling clone,   874/892
(97 %)
37 diff
(95.9 %id)
CR592504 placenta .vo 239 to 2037 3 to 1801 exact tiling clone,   1801/1801
(100 %)
0 diff
(100 %id)
AL540440 placenta .vo 239 to 1131 3 to 895 Q61* fully sequenced,   895/895
(100 %)
2 diff
(99.8 %id)
H12196 whole brain .vo 417 to 895 1 to 485       485/493
(98 %)
13 diff
(97.4 %id)
FN096006 breast carcinoma .vo 733 to 821 1 to 88       88/88
(100 %)
4 diff
(95.5 %id)
FN163581 breast carcinoma .vo 812 to 897 102 to 16     Submitted on the opposite strand 87/102
(85 %)
0 diff
(100 %id)
BX350796 Neuroblastoma Cot 10-normalized .vo 1110 to 1901 794 to 1       794/907
(87 %)
16 diff
(98.3 %id)
AL568411 placenta .vo 1645 to 2020 386 to 14   fully sequenced,   851/864
(98 %)
31 diff
(96.5 %id)
DA252820 caudate nucleus .vp 1 to 585 2 to 587   tiling clone, capped   586/586
(100 %)
2 diff
(99.7 %id)
AY302072   .vp 4 to 1873 1 to 1871 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1871/1871
(100 %)
2 diff
(99.9 %id)
DB137127 thymus .vq -8 to 533 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
AJ565851 brain .vq 1 to 683 2 to 684   tiling clone,   684/684
(100 %)
0 diff
(100 %id)
DB044670 testis .vq 19 to 571 2 to 557   capped   556/556
(100 %)
4 diff
(99.3 %id)
DA038246   .vq 24 to 592 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
R61256 whole brain .vq 25 to 450 1 to 428       428/431
(99 %)
9 diff
(98.0 %id)
DB008350 cervix, tumor tissue .vq 30 to 520 2 to 493   capped   492/492
(100 %)
1 diff
(99.8 %id)
AY208838 lung small cell carcinoma .vq 35 to 1089 104 to 1158   tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1055/1066
(98 %)
6 diff
(99.5 %id)
BC001628 Lung, small cell carcinoma .vq 40 to 1089 1 to 1050   available from MGC, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1050/1050
(100 %)
0 diff
(100 %id)
BM459369 lymph, lymphoma, cell line .vq 40 to 982 1 to 946 K103N H104I W105G N106I S107L ...     944/1015
(93 %)
16 diff
(98.5 %id)
NM_175071.1   .vq 40 to 1857 1 to 1818   RefSeq, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1818/1818
(100 %)
0 diff
(100 %id)
R61257 whole brain .vq 1271 to 1852 626 to 9   tiling clone,   618/627
(98 %)
0 diff
(100 %id)
DA759741   .vr 1 to 232 2 to 233 A27T tiling clone, capped   232/232
(100 %)
1 diff
(99.6 %id)
DB325271   .vr 1247 to 1803 554 to 1   tiling clone,   554/554
(100 %)
5 diff
(99.1 %id)
AY302073   .vs 1 to 1760 1 to 1761 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1761/1761
(100 %)
2 diff
(99.9 %id)
AY302074   .vt 1 to 1755 1 to 1756 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1756/1756
(100 %)
2 diff
(99.9 %id)
DN920458   .vt 376 to 701 1 to 326 P50S Q81X     326/326
(100 %)
1 diff
(99.7 %id)
BM083910 carcinoid, lung .vu 1 to 577 580 to 4 P15L L17F tiling clone,   577/580
(99 %)
3 diff
(99.5 %id)
BE467414 carcinoid, lung .vu 91 to 579 499 to 11 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 489/489
(100 %)
0 diff
(100 %id)
AW362120 colon .vu 201 to 567 15 to 381 Q47R     368/408
(90 %)
9 diff
(97.8 %id)
BX405535 fetal liver, Liver .vu 211 to 1286 1062 to 1 A5X G6V R7X V8Y T9C ...     1067/1071
(99 %)
29 diff
(97.3 %id)
BX423736 fetal liver, Liver .vu 234 to 1301 1068 to 1 G6X C24X L30R S33X tiling clone,   1068/1075
(99 %)
19 diff
(98.3 %id)
T81905 liver and spleen .vu 257 to 536 1 to 286 exact     286/288
(99 %)
9 diff
(96.9 %id)
BI255599 cervical carcinoma cell line, cervix .vu 258 to 1179 1 to 920 exact tiling clone,   920/920
(100 %)
24 diff
(97.4 %id)
AI798650 pooled .vu 265 to 582 319 to 1 exact     319/319
(100 %)
14 diff
(95.7 %id)
AI809888 pooled .vu 265 to 582 318 to 1 exact     318/318
(100 %)
0 diff
(100 %id)
N28509 melanocyte .vu 279 to 803 1 to 532 exact tiling clone,   532/533
(99 %)
10 diff
(98.2 %id)
T81906 liver and spleen .vu 1098 to 1332 238 to 1   tiling clone,   238/238
(100 %)
5 diff
(97.9 %id)
BX091959 liver and spleen .vv-u 1 to 760 1 to 761   tiling clone,   761/761
(100 %)
1 diff
(99.9 %id)
H64288 liver and spleen .vv-u 62 to 553 1 to 502   fully sequenced,   502/502
(100 %)
9 diff
(98.3 %id)
R94098 liver and spleen .vv-u 63 to 380 1 to 318       318/318
(100 %)
1 diff
(99.7 %id)
AA779333 liver and spleen .vv-u 530 to 1009 480 to 1 exact tiling clone,   480/480
(100 %)
1 diff
(99.8 %id)
H64289 liver and spleen .vv-u 539 to 994 456 to 1 exact fully sequenced,   456/456
(100 %)
7 diff
(98.5 %id)
BF929950 nervous_tumor .vv-u 740 to 1002 268 to 5 exact   Submitted on the opposite strand 264/268
(98 %)
0 diff
(100 %id)
R94068 liver and spleen .vv-u 803 to 992 190 to 1       190/190
(100 %)
0 diff
(100 %id)
BE089028 breast .vv-u 838 to 1120 1 to 287   tiling clone,   287/288
(99 %)
8 diff
(97.3 %id)
FN128523 breast carcinoma .vv-u 851 to 948 1 to 96       96/96
(100 %)
3 diff
(96.9 %id)
AA705531 liver and spleen .vv-u 887 to 983 97 to 1       97/97
(100 %)
0 diff
(100 %id)
DB050892 testis .vw 1 to 558 2 to 559   tiling clone, capped   558/558
(100 %)
1 diff
(99.9 %id)
DB190816 lung, tumor tissue .vw 39 to 620 2 to 583   tiling clone, capped   582/582
(100 %)
0 diff
(100 %id)
BQ049882 lymph, lymphoma, cell line .vw 59 to 1006 1 to 955 R44X K100X F108X N109H V119G ... tiling clone,   955/1051
(90 %)
11 diff
(99.0 %id)
BM798537 Ascites, stomach .vw 167 to 340 12 to 185       177/186
(95 %)
8 diff
(95.7 %id)
FN140795 breast carcinoma .vw 176 to 270 96 to 1     Submitted on the opposite strand 96/96
(100 %)
5 diff
(94.8 %id)
BE265789 lung, small cell carcinoma .vw 176 to 724 1 to 551   available from MGC,   551/551
(100 %)
3 diff
(99.5 %id)
N46741 multiple sclerosis lesions .vw 305 to 601 1 to 296       295/314
(93 %)
5 diff
(98.5 %id)
CN427105 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vx 1 to 590 1 to 588   tiling clone,   588/588
(100 %)
6 diff
(99.0 %id)
BQ232518 melanotic melanoma, skin .vx 67 to 905 1 to 842 L50A E51G P52T G53W S54E ... tiling clone,   842/863
(97 %)
14 diff
(98.4 %id)
AW953304   .vx 299 to 651 22 to 373       355/376
(94 %)
19 diff
(95.0 %id)
H22782.
matches multiple genes
whole brain .vx 299 to 668 11 to 386     also hits gene GRIA1 379/473
(80 %)
16 diff
(96.7 %id)
BM853051 Ascites, stomach .vx 321 to 686 1 to 366       366/366
(100 %)
0 diff
(100 %id)
DA604284   .vy -8 to 496 2 to 507   capped   506/506
(100 %)
1 diff
(99.9 %id)
BX643461   .vy 1 to 676 9 to 684       684/684
(100 %)
1 diff
(99.9 %id)
AJ565852 brain .vy 1 to 793 2 to 794   tiling clone,   794/794
(100 %)
0 diff
(100 %id)
BG825291 muscle, rhabdomyosarcoma .vy 1 to 759 2 to 762       762/762
(100 %)
6 diff
(99.3 %id)
BM927239 brain .vy 3 to 836 1 to 840 E144G V146G I147D V148C D149X ... tiling clone,   840/1063
(79 %)
14 diff
(98.7 %id)
DA566208 heart .vy 8 to 472 2 to 466   capped   465/465
(100 %)
0 diff
(100 %id)
BQ226853 melanotic melanoma, skin .vy 11 to 821 1 to 814   tiling clone,   814/906
(89 %)
8 diff
(99.2 %id)
CN427108 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vy 18 to 747 1 to 730       730/730
(100 %)
4 diff
(99.5 %id)
BE296158 muscle, rhabdomyosarcoma .vy 20 to 717 1 to 694       694/727
(95 %)
16 diff
(97.8 %id)
DB195503 trachea .vy 22 to 514 2 to 494   capped   493/493
(100 %)
0 diff
(100 %id)
BG828605 muscle, rhabdomyosarcoma .vy 23 to 801 1 to 783       783/853
(91 %)
22 diff
(97.5 %id)
BI819946 pooled brain, lung, testis .vy 23 to 821 1 to 787       787/787
(100 %)
16 diff
(98.0 %id)
TI_57198178   .vy 23 to 821 64 to 850       787/850
(92 %)
21 diff
(97.6 %id)
DT215678 brain .vy 26 to 641 1 to 616       616/616
(100 %)
3 diff
(99.6 %id)
CX755279 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .vy 26 to 784 1 to 756     Submitted on the opposite strand 756/756
(100 %)
5 diff
(99.4 %id)
DA384401 thalamus .vy 28 to 617 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA512806 brain .vy 28 to 749 2 to 729   capped   728/731
(99 %)
17 diff
(97.7 %id)
DA566653 heart .vy 28 to 600 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB010904 colon, tumor tissue .vy 28 to 607 2 to 582   capped   581/581
(100 %)
4 diff
(99.4 %id)
DB182133 liver, tumor tissue .vy 28 to 611 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DN994148 brain, whole brain .vy 53 to 657 67 to 671       671/671
(100 %)
5 diff
(99.3 %id)
CN287591 embryonic stem cells, cell lines H1, H7, andH9 .vz-u 1 to 532 1 to 533 R47K R60K tiling clone,   533/533
(100 %)
7 diff
(98.7 %id)
AW969683   .vz-u 6 to 390 110 to 493       384/493
(77 %)
6 diff
(98.8 %id)
BM548313 brain, hippocampus .vz-u 23 to 807 19 to 809 exact tiling clone,   791/1083
(73 %)
9 diff
(99.2 %id)
BU165305 eye, retinoblastoma .vz-u 77 to 742 1 to 676 exact tiling clone,   676/830
(81 %)
34 diff
(96.0 %id)
DB039718 testis .vz-u 156 to 728 2 to 575 exact tiling clone, capped   574/574
(100 %)
1 diff
(99.9 %id)
BG564551 Liver .wa-u 1 to 778 1 to 781 exact tiling clone,   781/783
(99 %)
24 diff
(97.0 %id)
BQ053911 blood, natural killer cells, cell line .wb-u 1 to 707 1 to 707 C6F tiling clone,   707/709
(99 %)
6 diff
(99.2 %id)
EC520953 Prostate .wb-u 618 to 739 1 to 113   tiling clone,   113/113
(100 %)
10 diff
(91.2 %id)
DA369972 subthalamic nucleus .wc 1 to 571 4 to 574 exact capped   573/573
(100 %)
1 diff
(99.9 %id)
CB989209 Human Placenta, placenta .wc 2 to 702 28 to 728 V2A tiling clone,   701/763
(91 %)
11 diff
(98.6 %id)
DA519110 brain .wc 5 to 549 2 to 546 N56E Q57S T58D S59F T60H ... tiling clone, capped   545/548
(99 %)
3 diff
(99.5 %id)
DA562393 heart .wc 11 to 585 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
AJ565850 brain .wd 1 to 678 2 to 679 exact tiling clone,   679/679
(100 %)
0 diff
(100 %id)
DA894492 skeletal muscle .wd 8 to 562 2 to 556 exact capped   555/555
(100 %)
0 diff
(100 %id)
DA511948 brain .wd 18 to 575 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA610730   .wd 27 to 561 2 to 537   capped   536/536
(100 %)
3 diff
(99.5 %id)
DA005529   .wd 28 to 599 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA063685 cerebellum .wd 28 to 591 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA471960   .we 1 to 553 2 to 556 R3L V4G C5V W6X L7G ... tiling clone, capped   555/555
(100 %)
3 diff
(99.5 %id)
DB034009 testis .we 12 to 584 2 to 574 R3X V4G C5V W6L L7V ... tiling clone, capped   573/573
(100 %)
3 diff
(99.5 %id)
BE782461 eye, retinoblastoma .wf 1 to 577 1 to 576 exact tiling clone,   576/676
(85 %)
3 diff
(99.6 %id)
DA456858 tongue, tumor tissue .wg 1 to 562 2 to 566 exact tiling clone, capped   565/565
(100 %)
3 diff
(99.5 %id)
DA686239   .wh 27 to 561 2 to 536 exact tiling clone, capped   535/535
(100 %)
0 diff
(100 %id)
DA707301   .wh 53 to 536 76 to 560 R3L V4G C5V W6L L7V ... capped   559/559
(100 %)
1 diff
(99.9 %id)
BQ312692 breast_normal Gene APTX, variant not shown         This clone was ignored    
DB299139 cerebellum Gene APTX, variant not shown              
DA101280 cerebellum Gene APTX, variant not shown       capped      
AA483002 Ewing's sarcoma Gene APTX, variant not shown              
AI217108   Gene APTX, variant not shown         This clone was ignored    
AW630763 2 pooled high-grade transitional celltumors, genitourinary tract Gene APTX, variant not shown              
DB325386 tongue Gene APTX, variant not shown         This clone was ignored    
DA763202 tongue Gene APTX, variant not shown       capped This clone was ignored    
DB326558.
matches multiple genes
brain Gene APTX, variant not shown         This clone was ignored, also hits gene speysuby    
DB326558.
matches multiple genes
brain Gene speysuby, variant not shown         This clone was ignored, also hits gene speysuby    
DA790252.
matches multiple genes
brain Gene APTX, variant not shown       capped This clone was ignored, also hits gene speysuby    
DA790252.
matches multiple genes
brain Gene speysuby, variant not shown       capped This clone was ignored, also hits gene speysuby    
DB063526 testis Gene APTX, variant not shown       capped This clone was ignored    
DB339489 testis Gene APTX, variant not shown         This clone was ignored    
TI_154105980   Gene APTX, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk, .vl, .vm, .vn, .vo, .vp, .vq, .vr, .vs, .vt, .vu, .vv-u, .vw, .vx, .vy, .vz-u, .wa-u, .wb-u, .wc, .wd, .we, .wf, .wg, .wh Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI